- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Millennix
Total 402 results
-
University of Massachusetts, WorcesterGenentech, Inc.; Millennium Pharmaceuticals, Inc.TerminatedLung CancerUnited States
-
Weill Medical College of Cornell UniversityMillennium Pharmaceuticals, Inc.CompletedNon-Hodgkin's LymphomaUnited States
-
Ohio State University Comprehensive Cancer CenterMillennium Pharmaceuticals, Inc.TerminatedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade... and other conditionsUnited States
-
Weill Medical College of Cornell UniversityMillennium Pharmaceuticals, Inc.CompletedNeuroendocrine Prostate Cancer | Small Cell Prostate Cancer | Prostate Adenocarcinoma Plus > 50% Immunohistochemical Staining for Neuroendocrine MarkersUnited States
-
Weill Medical College of Cornell UniversityMillennium Pharmaceuticals, Inc.Completed
-
Hoosier Cancer Research NetworkGenentech, Inc.; Millennium Pharmaceuticals, Inc.TerminatedLymphoma, Non-HodgkinUnited States
-
Emory UniversityGenentech, Inc.; Millennium Pharmaceuticals, Inc.; Schering-PloughCompletedGlioblastoma MultiformeUnited States
-
Emmanuel Antonarakis, MDMillennium Pharmaceuticals, Inc.WithdrawnProstate Cancer | Castration-resistant Prostate CancerUnited States
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.TerminatedFollicular LymphomaItaly, Israel, Germany, France, Greece, Spain, Switzerland
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedStudy of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaFrance, United States, Spain, Korea, Republic of, Australia, Israel, India, Thailand, China, Czech Republic, Belgium, New Zealand, Russian Federation, Finland, South Africa, United Kingdom, Italy, Brazil, Hungary, Puerto Rico, A... and more
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedAmyloidosisUnited States
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedTumors | Non-Hodgkins's LymphomaUnited States
-
Weill Medical College of Cornell UniversityPfizer; Millennium Pharmaceuticals, Inc.TerminatedMantle Cell LymphomaUnited States
-
Joseph TuscanoMillennium Pharmaceuticals, Inc.CompletedAcute Myelogenous LeukemiaUnited States
-
Weill Medical College of Cornell UniversityMillennium Pharmaceuticals, Inc.Completed
-
Northwestern UniversityEli Lilly and Company; Millennium Pharmaceuticals, Inc.Terminated
-
M.D. Anderson Cancer CenterMillennium: The Takeda Oncology CompanyTerminated
-
Masonic Cancer Center, University of MinnesotaMillennium Pharmaceuticals, Inc.TerminatedAcute Lymphoblastic LeukemiaUnited States
-
University of Michigan Rogel Cancer CenterMillennium Pharmaceuticals, Inc.CompletedNeuroblastomaUnited States
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedMultiple Myeloma | Non-Hodgkin's LymphomaIsrael, Italy, Poland, South Africa, United Kingdom
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Terminated
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.; Hartford HospitalActive, not recruiting
-
Icahn School of Medicine at Mount SinaiMillennium Pharmaceuticals, Inc.CompletedAL AmyloidosisUnited States
-
Kathy MillerMillennium Pharmaceuticals, Inc.; Big Ten Cancer Research ConsortiumTerminatedHCC | Hepatocellular Carcinoma | Liver CancerUnited States
-
Mehrdad Abedi, MDMillennium Pharmaceuticals, Inc.CompletedGraft Versus Host DiseaseUnited States
-
Oregon Health and Science UniversityMillennium: The Takeda Oncology CompanyCompletedMultiple Myeloma | Heart Failure, Systolic | Cardiotoxins
-
Weill Medical College of Cornell UniversityGlaxoSmithKline; Millennium Pharmaceuticals, Inc.CompletedNon-Hodgkin's LymphomaUnited States
-
University of CincinnatiGenzyme, a Sanofi Company; Millennium Pharmaceuticals, Inc.CompletedKidney TransplantationUnited States
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.TerminatedMetastatic Breast CancerUnited States
-
Eric Bernicker, MDMillennium Pharmaceuticals, Inc.; The Methodist Hospital Research InstituteWithdrawnCD30-positive Lymphoma | CD30-positive Solid TumorUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteMillennium Pharmaceuticals, Inc.CompletedMultiple Myeloma | Plasma Cell LeukemiaUnited States
-
PETHEMA FoundationMillennium Pharmaceuticals, Inc.; Johnson & Johnson Pharmaceutical Research...Completed
-
Memorial Sloan Kettering Cancer CenterMillennium: The Takeda Oncology CompanyCompletedMyeloid Hematologic Malignancy | Lymphoid Hematologic MalignancyUnited States
-
IpasSt. Paul's Hospital Millennium Medical College, Addis Ababa, EthiopiaCompletedMedical Abortion | Induced Abortion | Second Trimester Abortion | Health PersonnelEthiopia
-
Louisiana State University Health Sciences Center...Millennium Pharmaceuticals, Inc.WithdrawnFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone LymphomaUnited States
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedMantle Cell LymphomaChina, Belgium, Thailand, United States, Spain, Canada, Colombia, Italy, Morocco, Brazil, Turkey, Chile, Malaysia, Israel, Portugal, Singapore, Russian Federation, Philippines, Tunisia, Austria, Czechia, Germany, Hungary, India, Poland, R... and more
-
Women and Infants Hospital of Rhode IslandMillennium Pharmaceuticals, Inc.TerminatedCervical CancerUnited States
-
Vania Martínez-NahuelANID - Millennium Science Initiative Program - NCS17_03 Millennium Nucleus... and other collaboratorsTerminatedDepressive SymptomsChile
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.Active, not recruitingProstate CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.CompletedProstate CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.TerminatedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Ohio State University Comprehensive Cancer CenterMillennium Pharmaceuticals, Inc.; Celgene CorporationCompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; Millennium Pharmaceuticals, Inc.Completed
-
St. Jude Children's Research HospitalMillennium Pharmaceuticals, Inc.; Takeda Pharmaceuticals U.S.A., Inc.Active, not recruitingMalignant Rhabdoid Tumor | Atypical Teratoid Rhabdoid TumorUnited States
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); Pfizer; Millennium Pharmaceuticals, Inc.CompletedNon-Hodgkins LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.; Karyopharm Therapeutics IncCompletedMultiple Myeloma | Relapsed and/or Refractory Multiple MyelomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.Completed
-
University of Wisconsin, MadisonMerck Sharp & Dohme LLC; Millennium Pharmaceuticals, Inc.CompletedCarcinoma, Non Small Cell Lung
-
H. Lee Moffitt Cancer Center and Research InstituteMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
University of California, DavisNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.CompletedUnspecified Adult Solid Tumor, Protocol Specific | Mucinous Adenocarcinoma of the Rectum | Signet Ring Adenocarcinoma of the Rectum | Mucinous Adenocarcinoma of the Colon | Signet Ring Adenocarcinoma of the Colon | Stage IIIA Colon Cancer | Recurrent Colon Cancer | Recurrent Rectal CancerUnited States